XML 43 R14.htm IDEA: XBRL DOCUMENT
v2.4.1.9

STOCKHOLDERS' EQUITY | 9 Months Ended
--- | ---
Mar. 31, 2015
STOCKHOLDERS' EQUITY [Abstract] |
STOCKHOLDERS' EQUITY | NOTE 6: - STOCKHOLDERS' EQUITY
| a. | From July 2014 through March 2015, a total of 1,531,367 warrants were exercised via “cashless” exercise, resulting in the issuance of 694,326 shares of common stock to investors of the Company. In addition, 147,667 warrants were exercised for cash and resulted in the issuance of 147,667 shares of common stock to investors of the Company. The aggregate cash consideration received was $244.
| b. | In October 2014, the Company issued 200,000 shares of common stock to an investor, in a private placement. The aggregate cash consideration received was $528. In February 2015, the Company issued an additional 200,000 shares of common stock to an investor, in a private placement. The aggregate cash consideration received was $586.
| c. | In December 2014, the Company granted 100,004 shares of restricted stock to its new laboratories facility contractor. The shares of restricted stock are linked to performance milestones with respect to the building of new laboratories in the Company's leased facility. As of March 31, 2015, these milestones have not been met. The fair value of the restricted stock as of March 31, 2015, amounted to approximately $280.
| d. | Options, warrants and restricted stock units to employees, directors and consultants:
| 1. | Options to employees and directors: A summary of the Company's activity related to options granted to employees and directors under the Company's 2003 and 2005 option plans is as follows:
|  | Nine months ended March 31, 2015 (Unaudited) |
|  | Number |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Terms (in years) |  |  | Aggregate Intrinsic Value Price |
Options outstanding at beginning of period |  |  | 1,862,099 |  |  | $ | 3.73 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (8,000 | ) |  | $ | 0.88 |  |  |  |  |  |  |  |  |
Options forfeited |  |  | (423 | ) |  | $ | 4.40 |  |  |  |  |  |  |  |  |
Options outstanding at end of the period |  |  | 1,853,676 |  |  | $ | 3.74 |  |  |  | 2.37 |  |  | $ | 895 |
Options exercisable at the end of the period |  |  | 1,853,676 |  |  | $ | 3.74 |  |  |  | 2.37 |  |  | $ | 895 |
Options vested |  |  | 1,853,676 |  |  | $ | 3.74 |  |  |  | 2.37 |  |  | $ | 895 |
|  | Intrinsic value of exercisable options (the difference between the Company's closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on March 31, 2015. This amount changes based on the fair market value of the Company's common stock.
| 2. | Options and warrants to non-employees:
| A summary of the activity related to options and warrants to consultants is as follows:
|  | Nine months ended March 31, 2015 (Unaudited) |
|  | Number |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Terms (in years) |  |  | Aggregate Intrinsic Value Price |
Options and warrants outstanding at beginning of period |  |  | 252,000 |  |  | $ | 5.19 |  |  |  |  |  |  |  |  |
Options granted |  |  | 1,000 |  |  | $ | 0.00001 |  |  |  |  |  |  |  |  |
Options and warrants outstanding at end of the period |  |  | 253,000 |  |  | $ | 5.17 |  |  |  | 3.23 |  |  | $ | 297 |
Options and warrants exercisable at the end of the period |  |  | 252,000 |  |  | $ | 5.19 |  |  |  | 3.21 |  |  | $ | 294 |
Options and warrants vested and expected to vest |  |  | 253,000 |  |  | $ | 5.17 |  |  |  | 3.23 |  |  | $ | 297 |
Compensation expenses related to options and warrants granted to consultants were recorded as follows:
|  | Nine months ended March 31, |  |  | Three months ended March 31, |
|  | 2015 |  |  | 2014 |  |  | 2015 |  |  | 2014 |
Research and development expenses |  | $ | 1 |  |  | $ | 7 |  |  | $ | - |  |  | $ | 7 |
General and administrative expenses |  | $ | 1 |  |  |  | - |  |  | $ | 1 |  |  |  | - |
|  | $ | 2 |  |  | $ | 7 |  |  | $ | 1 |  |  | $ | 7 |
| 3. | Restricted stock units to employees and directors: During the nine month period ended March 31, 2015, the Company granted restricted stock units to several of the Company's employees and directors. The following table summarizes the activity related to unvested restricted stock units granted to employees and directors for the nine-month period ended March 31, 2015 (Unaudited):
| Number |
Unvested at the beginning of period | 1,589,432 |
Granted | 1,028,153 |
Forfeited | (22,676 | )
Vested | (1,021,757 | )
Unvested at the end of the period | 1,573,152 |
Expected to vest after March 31, 2015 | 1,510,189 |
Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:
|  | Nine months ended March 31, |  |  | Three months ended March 31, |
|  | 2015 |  |  | 2014 |  |  | 2015 |  |  | 2014 |
Research and development expenses |  | $ | 977 |  |  | $ | 656 |  |  | $ | 482 |  |  | $ | 442 |
General and administrative expenses |  |  | 1,735 |  |  |  | 3,299 |  |  |  | 592 |  |  |  | 1,196 |
|  | $ | 2,712 |  |  | $ | 3,955 |  |  | $ | 1,074 |  |  | $ | 1,638 |
Unamortized compensation expenses related to restricted stock units granted to employees and directors to be recognized over an average time of approximately 2 years is $2,388.
| 4. | Restricted stock units to consultants: During the nine month period ended March 31, 2015, the Company granted restricted stock units to several consultants and service providers. The following table summarizes the activity related to unvested restricted stock units granted to consultants for the nine months ended March 31, 2015:
| Number |
Unvested at the beginning of period | 15,250 |
Granted | 70,180 |
Forfeited | - |
Vested | (69,805 | )
Unvested at the end of the period | 15,625 |
Expected to vest after March 31, 2015 | 15,625 |
Compensation expenses related to restricted stock units granted to consultants were recorded as follows:
|  | Nine months ended March 31, |  |  | Three months ended March 31, |
|  | 2015 |  |  | 2014 |  |  | 2015 |  |  | 2014 |
Research and development expenses |  | $ | 110 |  |  | $ | 59 |  |  | $ | 33 |  |  | $ | 42 |
General and administrative expenses |  |  | 88 |  |  |  | 157 |  |  |  | 50 |  |  |  | 157 |
|  | $ | 198 |  |  | $ | 216 |  |  | $ | 83 |  |  | $ | 199 |

X
- Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(d),(e)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section C Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Article 4 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Preferred Stock -URI http://asc.fasb.org/extlink&oid=6521494 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644 Reference 17: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644 Reference 18: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph d -Article 4 Reference 19: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration